Does right ventricular gene therapy with a beta-adrenergic receptor kinase inhibitor improve survival after pulmonary artery banding?
Selective RV expression of betaARKct improves survival and morbidity after PA banding. This represents a novel therapeutic modality for clinical situations involving increased RV afterload.
The incidence of psoriasis in general practice had not changed between 1987/'88 en 1995. Referral pattern and prescription shifted towards the guidelines issued by the NHG.